Rashida Haq1,2, Amy Kong1, Pauline Gulasingam1. 1. Department of Medicine, Division of Hematology & Oncology, St. Michael's Hospital, Unity Health, Toronto, ON M5B 1W8, Canada. 2. Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
Abstract
Implementation of survivorship care plans remain a challenge. This quality improvement initiative aims to integrate personalized treatment plans (PTP) and care plans (PCP) into the existing workflow for breast cancer (BC) patients. Methods: Phase 1 was to identify multidisciplinary team members to generate and deliver PTP and PCP. Concurrently, Phase 2 was to deliver PTP and PCP to newly diagnosed invasive BC patients at chemotherapy initiation and completion, respectively. Iterative plan, do, study, act (PDSA) cycles were applied to refine the process. The proportion of information completed for PTP and PCP generation and its delivery by the care team were measured. Patient and provider satisfaction were also assessed. Implementation Process and Results: The care transfer facilitator (CTF) was identified to complete and deliver PTP, and their data entry increased from 0% to 76%, 80%, 92% consecutively during the last 4 PDSA cycles. PTP and PCP were provided to 85% of eligible BC patients. Patients agreed that PTP helped them to actively participate in their care (88%) and communicate with the oncology care team (86%). Primary care physicians agreed that PTP and PCP had the information needed to "stay in the loop" (80%), and oncologists agreed they should be incorporated into oncology clinics (100%). Conclusions: Integrating PTP and PCP generation and delivery into existing workflow has led to an increase in uptake, sustainability and provider buy-in. With limited resources, it remains difficult to find care team members to complete the forms. A dedicated personnel or survivorship clinic is required to successfully implement PTP and PCP as the standard of care.
Implementation of survivorship care plans remain a challenge. This quality improvement initiative aims to integrate personalized treatment plans (PTP) and care plans (PCP) into the existing workflow for breast cancer (BC) patients. Methods: Phase 1 was to identify multidisciplinary team members to generate and deliver PTP and PCP. Concurrently, Phase 2 was to deliver PTP and PCP to newly diagnosed invasive BC patients at chemotherapy initiation and completion, respectively. Iterative plan, do, study, act (PDSA) cycles were applied to refine the process. The proportion of information completed for PTP and PCP generation and its delivery by the care team were measured. Patient and provider satisfaction were also assessed. Implementation Process and Results: The care transfer facilitator (CTF) was identified to complete and deliver PTP, and their data entry increased from 0% to 76%, 80%, 92% consecutively during the last 4 PDSA cycles. PTP and PCP were provided to 85% of eligible BC patients. Patients agreed that PTP helped them to actively participate in their care (88%) and communicate with the oncology care team (86%). Primary care physicians agreed that PTP and PCP had the information needed to "stay in the loop" (80%), and oncologists agreed they should be incorporated into oncology clinics (100%). Conclusions: Integrating PTP and PCP generation and delivery into existing workflow has led to an increase in uptake, sustainability and provider buy-in. With limited resources, it remains difficult to find care team members to complete the forms. A dedicated personnel or survivorship clinic is required to successfully implement PTP and PCP as the standard of care.
Entities:
Keywords:
breast cancer; care plans; health services research; quality improvement; survivorship
Authors: Sarah A Birken; Alecia S Clary; Shampa Bernstein; Jamiyla Bolton; Miriam Tardif-Douglin; Deborah K Mayer; Allison M Deal; Sara R Jacobs Journal: J Oncol Pract Date: 2018-07-13 Impact factor: 3.840
Authors: Mary S McCabe; Smita Bhatia; Kevin C Oeffinger; Gregory H Reaman; Courtney Tyne; Dana S Wollins; Melissa M Hudson Journal: J Clin Oncol Date: 2013-01-07 Impact factor: 44.544
Authors: Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544
Authors: Kim A H Nicolaije; Nicole P M Ezendam; M Caroline Vos; Johanna M A Pijnenborg; Dorry Boll; Erik A Boss; Ralph H M Hermans; Karin C M Engelhart; Joke E Haartsen; Brenda M Pijlman; Ingrid E A M van Loon-Baelemans; Helena J M M Mertens; Willem E Nolting; Johannes J van Beek; Jan A Roukema; Wobbe P Zijlstra; Roy F P M Kruitwagen; Lonneke V van de Poll-Franse Journal: J Clin Oncol Date: 2015-08-24 Impact factor: 44.544
Authors: Kate K Watabayashi; Ari Bell-Brown; Karma Kreizenbeck; Kathryn Egan; Gary H Lyman; Dawn L Hershman; Kathryn B Arnold; Aasthaa Bansal; William E Barlow; Sean D Sullivan; Scott D Ramsey Journal: BMC Health Serv Res Date: 2022-04-01 Impact factor: 2.655